ACCD Stock Summary and Trading Ideas (Accolade | NASDAQ:ACCD)

Accolade Inc offers technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. The company's platform combines open, cloud-based intelligent technology with multimodal support from a team of Accolade Care Advocates and clinicians, including registered nurses, physician medical directors, pharmacists, primary care physicians, and other professionals to provide advocacy, medical opinion, and virtual primary care services.

Accolade trades on the NASDAQ stock market under the symbol ACCD.

As of January 27, 2025, ACCD stock price climbed to $6.90 with 2,906,037 million shares trading.

ACCD has a beta of 0.00, meaning it tends to be less sensitive to market movements. ACCD has a correlation of 0.00 to the broad based SPY ETF.

ACCD has a market cap of $563.58 million. This is considered a Small Cap stock.

Last quarter Accolade reported $105 million in Revenue and -$.30 earnings per share. This fell short of revenue expectation by $-929,000 and missed earnings estimates by -$.14.

In the last 3 years, ACCD traded as high as $22.92 and as low as $3.08.

The top ETF exchange traded funds that ACCD belongs to (by Net Assets): ARKG, IWM, VTI, VXF, IWN.

ACCD has underperformed the market in the last year with a price return of -43.2% while the SPY ETF gained +24.4%. However, in the short term, ACCD had mixed performance relative to the market. It has outperformed in the last 3 months, returning +116.3% vs +3.9% return in SPY. But in the last 2 weeks, ACCD shares have been beat by the market, returning +1.0% compared to an SPY return of +3.1%.

ACCD support price is $6.66 and resistance is $7.12 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ACCD shares will trade within this expected range on the day.